Literature DB >> 23343772

Phospho-ΔNp63α/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposure.

Yiping Huang1, Dafna Kesselman, Darya Kizub, Rafael Guerrero-Preston, Edward A Ratovitski.   

Abstract

Our previous reports showed that the cisplatin exposure induced the ATM-dependent phosphorylation of ΔNp63a, which is subsequently involved in transcriptional regulation of gene promoters encoding mRNAs and microRNAs in squamous cell carcinoma (SCC) cells upon cisplatin-induced cell death. We showed that phosphorylated (p)-ΔNp63a plays a role in upregulation of pro-apoptotic proteins, while non-p-ΔNp63a is implicated in pro-survival signaling. In contrast to non-p-ΔNp63a, p-ΔNp63a modulated expression of specific microRNAs in SCC cells exposed to cisplatin. These microRNAs were shown to attenuate the expression of several proteins involved in cell death/survival, suggesting the critical role for p-ΔNp63a in regulation of tumor cell resistance to cisplatin. Here, we studied the function of ΔNp63a in transcriptional activation and repression of the specific microRNA promoters whose expression is affected by cisplatin treatment of SCC cells. We quantitatively studied chromatin-associated proteins bound to tumor protein (TP) p63-responsive element, we found that p-ΔNp63a along with certain transcription coactivators (e.g., CARM1, KAT2B, TFAP2A, etc.) necessary to induce gene promoters for microRNAs (630 and 885-3p) or with transcription corepressors (e.g., EZH2, CTBP1, HDACs, etc.) needed to repress promoters for microRNAs (181a-5p, 374a-5p and 519a-3p) in SCC cells exposed to cisplatin.

Entities:  

Keywords:  DNA/protein interactions; cisplatin; microRNAs; p53; p63; squamous cell carcinomas

Mesh:

Substances:

Year:  2013        PMID: 23343772      PMCID: PMC3594269          DOI: 10.4161/cc.23598

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  82 in total

1.  Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells.

Authors:  Y Huang; A Chuang; H Hao; C Talbot; T Sen; B Trink; D Sidransky; E Ratovitski
Journal:  Cell Death Differ       Date:  2011-01-28       Impact factor: 15.828

2.  RBP-Jkappa/SHARP recruits CtIP/CtBP corepressors to silence Notch target genes.

Authors:  Franz Oswald; Michael Winkler; Ying Cao; Kathy Astrahantseff; Soizic Bourteele; Walter Knöchel; Tilman Borggrefe
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  SSRP1 functions as a co-activator of the transcriptional activator p63.

Authors:  Shelya X Zeng; Mu-Shui Dai; David M Keller; Hua Lu
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

4.  Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation.

Authors:  Yiping Huang; Rafael Guerrero-Preston; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

5.  Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma.

Authors:  Matthew R Ramsey; Lei He; Nicole Forster; Benjamin Ory; Leif W Ellisen
Journal:  Cancer Res       Date:  2011-04-28       Impact factor: 12.701

6.  Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B.

Authors:  Angel G Martin; Jason Trama; Diane Crighton; Kevin M Ryan; Howard O Fearnhead
Journal:  Aging (Albany NY)       Date:  2009-02-18       Impact factor: 5.682

7.  Yin yang 1 modulates taxane response in epithelial ovarian cancer.

Authors:  Noriomi Matsumura; Zhiqing Huang; Tsukasa Baba; Paula S Lee; Jason C Barnett; Seiichi Mori; Jeffrey T Chang; Wen-Lin Kuo; Alison H Gusberg; Regina S Whitaker; Joe W Gray; Shingo Fujii; Andrew Berchuck; Susan K Murphy
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

8.  Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer.

Authors:  Iver Nordentoft; Lars Dyrskjøt; Julie S Bødker; Peter J Wild; Arndt Hartmann; Simone Bertz; Jan Lehmann; Torben F Orntoft; Karin Birkenkamp-Demtroder
Journal:  BMC Cancer       Date:  2011-04-14       Impact factor: 4.430

Review 9.  The DNA damage response: Balancing the scale between cancer and ageing.

Authors:  Elena G Seviour; Shiaw-Yin Lin
Journal:  Aging (Albany NY)       Date:  2010-12       Impact factor: 5.682

10.  HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.

Authors:  Euan A Stronach; Albandri Alfraidi; Nona Rama; Christoph Datler; James B Studd; Roshan Agarwal; Tankut G Guney; Charlie Gourley; Bryan T Hennessy; Gordon B Mills; Antonello Mai; Robert Brown; Roberto Dina; Hani Gabra
Journal:  Cancer Res       Date:  2011-05-13       Impact factor: 12.701

View more
  11 in total

1.  Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.

Authors:  Edward A Ratovitski
Journal:  Cell Cycle       Date:  2014-01-06       Impact factor: 4.534

2.  ΔNp63α Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas.

Authors:  Christopher G Abraham; Michael P Ludwig; Zdenek Andrysik; Ahwan Pandey; Molishree Joshi; Matthew D Galbraith; Kelly D Sullivan; Joaquin M Espinosa
Journal:  Cell Rep       Date:  2018-09-18       Impact factor: 9.423

3.  MicroRNA expression profile and functional analysis reveal that miR-206 is a critical novel gene for the expression of BDNF induced by ketamine.

Authors:  Xiaolin Yang; Qinyan Yang; Xiaobin Wang; Chunqiong Luo; Yunqiang Wan; Jiali Li; Kezhi Liu; Min Zhou; Chunxiang Zhang
Journal:  Neuromolecular Med       Date:  2014-05-18       Impact factor: 3.843

Review 4.  The microRNA feedback regulation of p63 in cancer progression.

Authors:  Changwei Lin; Xiaorong Li; Yi Zhang; Yihang Guo; Jianyu Zhou; Kai Gao; Jing Dai; Gui Hu; Lv Lv; Juan Du; Yi Zhang
Journal:  Oncotarget       Date:  2015-04-20

5.  Tumor Protein p63/microRNA Network in Epithelial Cancer Cells.

Authors:  Edward A Ratovitski
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

Review 6.  Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.

Authors:  Vivien Landré; Barak Rotblat; Sonia Melino; Francesca Bernassola; Gerry Melino
Journal:  Oncotarget       Date:  2014-09-30

7.  Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppression.

Authors:  Jing Dai; Hao Wu; Yi Zhang; Kai Gao; Gui Hu; Yihang Guo; Changwei Lin; Xiaorong Li
Journal:  Oncotarget       Date:  2016-12-27

8.  The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer.

Authors:  Marco Napoli; Elsa R Flores
Journal:  RNA Biol       Date:  2020-01-07       Impact factor: 4.652

9.  p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase Itch.

Authors:  Sonia Melino; Alessia Bellomaria; Ridvan Nepravishta; Maurizio Paci; Gerry Melino
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Alleviation of Toxicity Caused by Overactivation of Pparα through Pparα-Inducible miR-181a2.

Authors:  Yanjie Cheng; Zhuying Wei; Shengsong Xie; You Peng; Yi Yan; Dan Qin; Shenghui Liu; Yanling Xu; Guangpeng Li; Lisheng Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2017-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.